​

Funding Round

Series A - Renalys Pharma

Series A - Renalys Pharma

Investment Firm

Overview

Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.

Announced Date

Jul 17, 2024

Closed on Date

Jul 17, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Catalys Pacific

Catalys Pacific

Catalys Pacific is a early_stage_venture and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorCatalys Pacific
Participant InvestorJapan Post Investment
Participant InvestorSR One

Round Details and Background

Renalys Pharma raised $37956446 on 2024-07-17 in Series A

Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 17, 2024
Series A - Renalys Pharma
6-38.0M

Recent Activity

There is no recent news or activity for this profile.